Twentyeight-Seven Therapeutics

Twentyeight-Seven Therapeutics is a biotechnology company headquartered in Massachusetts, USA, focusing on modulating non-coding RNA (ncRNA) to develop therapies for cancer and other diseases. By targeting ncRNA regulatory proteins (RMPs), the company can use small molecules to modulate the expression levels of oncogenes and other crucial proteins.